Dermacyd PH_DESILSTY_FR (Lactic Acid) - Photo Evaluation - Stay on Frutal
Phase 3
Completed
- Conditions
- Hygiene
- Interventions
- Drug: LACTIC ACID(ND)
- Registration Number
- NCT00933257
- Lead Sponsor
- Sanofi
- Brief Summary
Primary Objective:
To demonstrate the absence of photoirritation and potential photosensitization of the product Dermacyd PHDESILSTYFR.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Dermacyd PH_DESILSTY_FR (Lactic Acid) LACTIC ACID(ND) Dermacyd PH_DESILSTY_FR (Lactic Acid) sample will be applied like a curative. Physiologic solution and mineral oil will be also used as a control sample.
- Primary Outcome Measures
Name Time Method Measure of the photo irritation test and the photosensitivity byusing UVA irradiation and evaluation according to International Contact Dermatitis Research Group (ICDRG) scale. Evaluation of the sensibility according to the skin type. From the treatment start to the end of the study (treatment period 5 weeks)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie lactic acid's photoirritation and photosensitization effects in dermatological applications?
How does lactic acid (Dermacyd PH_DESILSTY_FR) compare to other alpha hydroxy acids in photo protection efficacy for skin hygiene?
Are there specific biomarkers that correlate with reduced photoirritation risk when using lactic acid-based dermatological products?
What adverse events are associated with lactic acid formulations in phase 3 trials for skin-related conditions, and how are they managed?
What are the current combination therapies involving lactic acid for enhancing skin barrier function and photoprotection in clinical practice?
Trial Locations
- Locations (1)
Sanofi-Aventis Administrative Office
🇧🇷Sao Paulo, Brazil
Sanofi-Aventis Administrative Office🇧🇷Sao Paulo, Brazil